Search

Search Results
Results 6811 - 6820 of 6866 for autoimmune
  • Drug - 26 Jul 2024
    Consumer Medicine Information (CMI) about Intelence (etravirine) intended for persons living in Australia.
  • White Paper - 6 Mar 2019
    Glycosylation in the blood plasma is not fully understood yet holds therapeutic potential. Here, it is explored with CID-MS²/MS³.
  • Health - 27 Feb 2019
    Rickets has been around for centuries, but its roots as a symptom of vitamin D deficiency began only in the 17th century, when Francis Glisson published his findings on the disease and proposed that...
  • News - 18 Feb 2010
    Incyte Corporation today reported fourth quarter and full year 2009 financial results, provided an update on key fourth quarter accomplishments and 2010 objectives, and announced its 2010 financial...
  • Drug - 7 Jan 2025
    Consumer Medicine Information (CMI) about Tryzan intended for persons living in Australia.
  • Drug - 18 Dec 2024
    Consumer Medicine Information (CMI) about Tevimbra intended for persons living in Australia.
  • Drug - 2 Dec 2024
    Consumer Medicine Information (CMI) about Ilaris intended for persons living in Australia.
  • Drug - 12 Nov 2024
    Consumer Medicine Information (CMI) about Triasyn intended for persons living in Australia.
  • Drug - 10 Nov 2024
    Consumer Medicine Information (CMI) about Methoblastin Blister intended for persons living in Australia.
  • Drug - 8 Nov 2024
    Consumer Medicine Information (CMI) about Tysabri intended for persons living in Australia.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.